UKCA Marking & Transition Rules for Medical Devices – Online Training (Apr 15, 2026)

This comprehensive online training course is specifically designed for medical device manufacturers and industry professionals seeking to understand, prepare for, and successfully navigate the evolving regulatory requirements governing the placement of medical devices on the UK market. As the United…

Read MoreUKCA Marking & Transition Rules for Medical Devices – Online Training (Apr 15, 2026)

Anthem Blue Cross and Blue Shield, United Digestive Enter Multi-Year Agreement

United Digestive to Remain In-Network for Anthem Members Across Georgia Under New Multi-Year Agreement Anthem Blue Cross and Blue Shield today announced a new, multi-year provider network agreement with United Digestive, ensuring continued in-network access to comprehensive gastrointestinal (GI) care…

Read MoreAnthem Blue Cross and Blue Shield, United Digestive Enter Multi-Year Agreement

Verastem Oncology Issues Inducement Grants Under Nasdaq Rule 5635(c)(4)

Verastem Oncology a clinical-stage biopharmaceutical company dedicated to the development and commercialization of novel therapies for patients with cancers driven by aberrations in the RAS/MAPK signaling pathway, today announced the issuance of equity-based inducement awards to newly hired employees as…

Read MoreVerastem Oncology Issues Inducement Grants Under Nasdaq Rule 5635(c)(4)

Thermo Fisher and NVIDIA Collaborate to Accelerate Lab Performance Using AI

Thermo Fisher Scientific and NVIDIA Form Strategic Alliance to Transform Laboratories Through AI and Automation Thermo Fisher Scientific a global leader in scientific services and laboratory technologies, has announced a strategic collaboration with NVIDIA aimed at accelerating the adoption of…

Read MoreThermo Fisher and NVIDIA Collaborate to Accelerate Lab Performance Using AI

Travere Therapeutics Announces Corporate Update and 2026 Strategic Outlook

Travere Therapeutics Reports Record FILSPARI Performance in 4Q 2025, Advances Regulatory and Clinical Milestones Ahead of 2026 Travere Therapeutics a biopharmaceutical company focused on developing and delivering transformative therapies for people living with rare kidney and metabolic diseases, today announced…

Read MoreTravere Therapeutics Announces Corporate Update and 2026 Strategic Outlook

Aptar Introduces Blink-Beating Eye Care Technology for Improved Dosing Precision

Aptar Expands Its Advanced Eye Care Portfolio with Innovative Delivery Technologies Designed to Improve Precision, Safety, and Patient Experience AptarGroup, a global leader in drug delivery, dispensing, and protection technologies for pharmaceutical, consumer healthcare, and personal care markets, has unveiled…

Read MoreAptar Introduces Blink-Beating Eye Care Technology for Improved Dosing Precision

Jupiter Medical Center Joins HSS to Enhance Orthopedic Services

Partnership Expands Access to Advanced Orthopedic and Musculoskeletal Care Across South Florida Jupiter Medical Center and Hospital for Special Surgery (HSS), the nation’s top-ranked orthopedic hospital, have announced a strategic collaboration aimed at significantly expanding access to world-class musculoskeletal care…

Read MoreJupiter Medical Center Joins HSS to Enhance Orthopedic Services

BCG, Hippocratic AI Partner to Deploy Agentic AI in Biopharma, Medtech

BCG and Hippocratic AI Join Forces to Drive Real-World Generative AI Impact Across Biopharma and Medtech Boston Consulting Group (BCG) and Hippocratic AI today announced a global strategic collaboration designed to accelerate the adoption of responsible, real-world generative artificial intelligence…

Read MoreBCG, Hippocratic AI Partner to Deploy Agentic AI in Biopharma, Medtech

Diorasis Therapeutics Names Richard A. Kresch, MD to Board of Directors

Appointment Strengthens Company’s Expertise in Translational Medicine and Commercial Strategy Diorasis Therapeutics, a biotechnology company based in Boston and focused on developing durable gene therapies for glaucoma and other ophthalmic disorders, has announced the appointment of Richard A. Kresch, MD,…

Read MoreDiorasis Therapeutics Names Richard A. Kresch, MD to Board of Directors